Mersana Therapeutics
Why Robinhood?
You can watch MRSN and buy or sell other stocks, ETFs, and their options commission-free!About MRSN
Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of antibody-drug conjugates that offer clinical benefit for cancer patients. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592.
MRSN Key Statistics
Stock Snapshot
The current Mersana Therapeutics(MRSN) stock price is $29.08, with a market capitalization of 4.07B. The stock trades at a price-to-earnings (P/E) ratio of -12.83.
On 2026-03-04, Mersana Therapeutics(MRSN) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Mersana Therapeutics(MRSN) stock has reached 0, versus its average volume of 2.98M.
The stock's 52-week range extends from a low of $0.26 to a high of $2.83.
The stock's 52-week range extends from a low of $0.26 to a high of $2.83.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.